Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Funding Announcements: August 2011

The following new grants were awarded to JCCC members in August 2011:

.Principal Investigator: Utpal Banerjee

Sponsor Name: NIH/National Institute of Allergy and Infectious Diseases

Award Title: "A Drosophila Model for NFKB and Prostaglandin Dependent Inflammatory Response"

Principal Investigator: Kenneth Bradley

Sponsor Name: NIH/National Institute of General Medical Sciences

Award Title: "Cellular Intoxication Pathway of Cytolethal Distending Toxin"

Principal Investigator: Bartosz Chmielowski

Sponsor Name: Eisai America, Inc.

Award Title: "A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma"

Principal Investigator: Bartosz Chmielowski

Sponsor Name: Infinity Pharmaceuticals, Inc. 

Award Title: "A Phase 2, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of IPI-926 in Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma"

Principal Investigator: Bartosz Chmielowski

Sponsor Name: Morphotek, Inc. (Japan) 

Award Title: "A Study of the Efficacy and PK/PD Relationship of Monotherapy MORAb-004 in Subjects with Metastatic Melanoma"

Principal Investigator: Samson Chow

Sponsor Name: NIH/National Institute of General Medical Sciences

Award Title: "Role of HIV-1 In During Reverse Transcription and Uncoating"

Principal Investigator: Sven De Vos

Sponsor Name: Inc Research

Award Title: "A Phase 2 Study to Assess the Efficacy and Safety of CAL-101 in Patients with Indolent B-Cell Non-Hodgkin Lymphoma Refractory to Rituximab and Alkylating Agents"

Principal Investigator: Noah Federman

Sponsor Name: Pharmaceutical Research Associates, Inc.

Award Title: "An Open-Label, Multicenter Study of the Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tables In Opioid Experienced Children from Ages 6 to 16 Years Old, Inclusive, with Moderate to Severe Malignant and/or Nonmalignant Pain Requiring Opioid Analgesic"

Principal Investigator: Richard Finn

Sponsor Name: Bayer/Columbia University

Award Title: "A Phase I Open-Label, Dose-Finding Study of BAY 43-9006 (Sofafenib) in High-Risk Hepatocellular Cancer Patients After Liver Transplantation"

Principal Investigator: Richard Finn

Sponsor Name: Meso Scale Discovery

Award Title: "Pharmacodynamic Assays for Cancer Therapeutics"

Principal Investigator: Richard Finn

Sponsor Name: Arqule Inc.

Award Title: "A Preclinical Research Program to Evaluate Predictors of Response for Arqule BRAF Inhibitor XXX"

Principal Investigator: John R. Froines

Sponsor Name: Clarence E. Heller Charitable Foundation

Award Title: "Risk and Decision: Evaluating Pesticide Approval in California"

Principal Investigator: Lillian Gelberg

Sponsor Name: Veterans Affairs (including VA Medical Centers) 

Award Title: "The VA Assessment and Improvement Laboratory for Patient-Centered Care Project (Vail-PCC)"

Principal Investigator: David Heber

Sponsor Name: Hass Avocado Board

Award Title: "Hass Avocados Flesh Inhibition of Lipid Peroxidation Products When Added To A Ground Beef Patty Consumed By Health Volunteers"

Principal Investigator: Fairooz F. Kabbinavar

Sponsor Name: Bristol-Myers Squibb Company

Award Title: "A Randomized, Blinded, Phase 2 Dose-Ranging Study of BMS-936558 (MDX-1106) in Subjects with Progressive, Advanced/Metastatic Clear-Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy"

Principal Investigator: Kasahara, Noriyuki

Sponsor Name: Cal Institute for Regenerative Medicine (CIRM)

Award Title: "Stem-Cell Based Carriers for RCR Vector Delivery to Glioblastoma"

Principal Investigator: Albert Lai

Sponsor Name: Millennium Pharmaceuticals, Inc. 

Award Title: "Phase II Trial of Velcade (Bortezomib) in Combination With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients with Newly-diagnosed Glioblastoma Multiforme"

Principal Investigator: Albert Lai

Sponsor Name: American Brain Tumor Association

Award Title: "Characterization of Mgmt Promoter Methylation Using an Episomal Cell Culture System (Fellow: Yiannis Philippou)"

Principal Investigator: Leonard S. Marks

Sponsor Name: NIH/National Cancer Institute 

Award Title: "Biopsy Tracking and MRI Fusion to Enhance Imaging of Cancer Within the Prostate"

Principal Investigator: William H. McBride

Sponsor Name: U.S. Army/Medical Research Acquisition Activity

Award Title: "Radiation-Induced Vaccination to Breast Cancer"

Principal Investigator: Paul Mischel

Sponsor Name: Celgene Corporation

Award Title: "CC223 Research Plan for IHC Biomarker Studies"

Principal Investigator: Ronald T. Mitsuyasu

Sponsor Name: NIH/National Institute of Mental Health

Award Title: "South American Prevention of HIV Research Training Program (Saphir)"

Principal Investigator: Allan Pantuck

Sponsor Name: U.S. Army/Medical Research Acquisition Activity

Award Title: "Early Diagnosis of Clear Cell Kidney Cancer Via VHL/Hifpathway-Regulated Circulating Microrna"

Principal Investigator: Jeanette Papp

Sponsor Name: NIH/National Human Genome Research Institute

Award Title: "Middle School/Graduate School Joint Enrichment Partnership"

Principal Investigator: Kathrin Plath

Sponsor Name: NIH/National Institute of General Medical Sciences

Award Title: "Molecular and Architectural Mechanisms of Reprogramming to Pluripotency"

Principal Investigator: Caius G. Radu

Sponsor Name: NIH/National Cancer Institute

Award Title: "Novel Molecular Imaging Approaches to Monitor Gene and Cell-Based Therapies"

Principal Investigator: Yi Sun

Sponsor Name: Cal Institute for Regenerative Medicine (CIRM)

Award Title: "Studying Neurotransmission of Normal and Diseased Human ES Cell-Derived Neurons In Vivo"

Principal Investigator: Hsian-Rong Tseng

Sponsor Name: NIH/National Institute of General Medical Sciences

Award Title: "Generation of Hpscs Using Reprogramming Proteins-Encapsulated Nanoparticles"

Principal Investigator: Zev Wainberg

Sponsor Name: Amgen

Award Title: "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Trial of AMG 479 or Placebo in Combination With Gemcitabine as First Line Therapy for Metastatic Adenocarcinoma of the Pancreas"

Principal Investigator: David Wong

Sponsor Name: UC Tobacco-Related Disease Research Program

Award Title: "Salivary Biomarkers Development for Detection of Lung Cancer"

Principal Investigator: Jerome A. Zack

Sponsor Name: NIH/National Institute of Allergy and Infectious Diseases/University of North Carolina

Award Title: "Eradication of HIV Reservoirs In Vivo"

 

Last updated: 10/6/2011 10:48:53 AM